Members of the CARE™ Hematology Faculty recently met at the CARE™ Winter Hematology Update (WHU) 2020 (February 2020, Toronto ON). As an extension of this meeting, CLL and MM specific insights were discussed with select Faculty in conjunction with the WHU conference. The aim was to review relevant news and data from a Canadian perspective and provide insight on the potential impact to clinical practice as we move forward in 2020.
What follows is a distillation of perspectives discussed and augmented with supporting data and information from recent major events (i.e. ASH 2019) for currently available (approved) options.